Abstract:The bidirectional communication between the immune and nervous system is important in regulating immune responses. Here we show that the adrenergic nerves of sympathetic nervous system orchestrate inflammation resolution and regenerative programs by modulating repulsive guidance molecule A (RGM-A). In murine peritonitis, adrenergic nerves and RGM-A show bidirectional activation by stimulating the mutual expression and exhibit a higher potency for the cessation of neutrophil infiltration; this reduction is acco… Show more
“…. The gating strategy can be found in SI Appendix, S13 (45). For therapeutic treatment with SH42, peritonitis was initiated as described above using 1 mL of a zyA solution.…”
Section: Methodsmentioning
confidence: 99%
“…Targeted LM Analysis. Targeted LM analysis was carried out as described elsewhere (45). Further details are available in SI Appendix, S16 and Table S1, and raw data are available in Dataset S6.…”
Section: Methodsmentioning
confidence: 99%
“…As a next step in integrating our results with inflammation resolution, we focused on monocyte differentiation and MΦ phenotypes as both processes are crucial for inflammation resolution. As cell shape and MΦ phenotype are correlated (44), we carried out cell shape analysis assessing monocyte differentiation toward the M1 or M2 phenotype (45). As can be seen in Fig.…”
Section: Protein Array Analysis Of the Phosphatidylinositol 3-kinase/mentioning
Targeting metabolism through bioactive key metabolites is an upcoming future therapeutic strategy. We questioned how modifying intracellular lipid metabolism could be a possible means for alleviating inflammation. Using a recently developed chemical probe (SH42), we inhibited distal cholesterol biosynthesis through selective inhibition of Δ24-dehydrocholesterol reductase (DHCR24). Inhibition of DHCR24 led to an antiinflammatory/proresolving phenotype in a murine peritonitis model. Subsequently, we investigated several omics layers in order to link our phenotypic observations with key metabolic alterations. Lipidomic analysis revealed a significant increase in endogenous polyunsaturated fatty acid (PUFA) biosynthesis. These data integrated with gene expression analysis, revealing increased expression of the desaturase Fads6 and the key proresolving enzyme Alox-12/15. Protein array analysis, as well as immune cell phenotype and functional analysis, substantiated these results confirming the antiinflammatory/proresolving phenotype. Ultimately, lipid mediator (LM) analysis revealed the increased production of bioactive lipids, channeling the observed metabolic alterations into a key class of metabolites known for their capacity to change the inflammatory phenotype.
“…. The gating strategy can be found in SI Appendix, S13 (45). For therapeutic treatment with SH42, peritonitis was initiated as described above using 1 mL of a zyA solution.…”
Section: Methodsmentioning
confidence: 99%
“…Targeted LM Analysis. Targeted LM analysis was carried out as described elsewhere (45). Further details are available in SI Appendix, S16 and Table S1, and raw data are available in Dataset S6.…”
Section: Methodsmentioning
confidence: 99%
“…As a next step in integrating our results with inflammation resolution, we focused on monocyte differentiation and MΦ phenotypes as both processes are crucial for inflammation resolution. As cell shape and MΦ phenotype are correlated (44), we carried out cell shape analysis assessing monocyte differentiation toward the M1 or M2 phenotype (45). As can be seen in Fig.…”
Section: Protein Array Analysis Of the Phosphatidylinositol 3-kinase/mentioning
Targeting metabolism through bioactive key metabolites is an upcoming future therapeutic strategy. We questioned how modifying intracellular lipid metabolism could be a possible means for alleviating inflammation. Using a recently developed chemical probe (SH42), we inhibited distal cholesterol biosynthesis through selective inhibition of Δ24-dehydrocholesterol reductase (DHCR24). Inhibition of DHCR24 led to an antiinflammatory/proresolving phenotype in a murine peritonitis model. Subsequently, we investigated several omics layers in order to link our phenotypic observations with key metabolic alterations. Lipidomic analysis revealed a significant increase in endogenous polyunsaturated fatty acid (PUFA) biosynthesis. These data integrated with gene expression analysis, revealing increased expression of the desaturase Fads6 and the key proresolving enzyme Alox-12/15. Protein array analysis, as well as immune cell phenotype and functional analysis, substantiated these results confirming the antiinflammatory/proresolving phenotype. Ultimately, lipid mediator (LM) analysis revealed the increased production of bioactive lipids, channeling the observed metabolic alterations into a key class of metabolites known for their capacity to change the inflammatory phenotype.
“…Thus, a recent report highlighted a novel facet of inflammatory reflexes in that adrenergic nerve fibres of the sympathetic nervous system together with the NGP Repulsive Guidance Molecule A (RGM-A) regulate the resolution of acute inflammation and promote tissue regeneration (Figure 2). 47 The protein RGM-A was shown to substantially influence the initial phase of acute inflammation and the pathobiology of autoimmune encephalomyelitis. 43,48,49 In a study by Körner and colleagues, 47 Notes: The adrenergic nerve together with the neuronal guidance protein RGM-A activate resolution programmes.…”
Section: Sympathetic Nerve In Resolution and Tissue Regenerationmentioning
confidence: 99%
“…47 The protein RGM-A was shown to substantially influence the initial phase of acute inflammation and the pathobiology of autoimmune encephalomyelitis. 43,48,49 In a study by Körner and colleagues, 47 Notes: The adrenergic nerve together with the neuronal guidance protein RGM-A activate resolution programmes. RGM-A enhances the expression of the β2 adrenergic receptor (β2AR) on human MΦs, and activation of β2AR, in turn, increases RGM-A expression on MΦs.…”
Section: Sympathetic Nerve In Resolution and Tissue Regenerationmentioning
Nonresolving inflammation, a hallmark of underlying severe inflammatory processes such as sepsis, acute respiratory distress syndrome and multiple organ failure is a major cause of admission to the intensive care unit and high mortality rates. Many survivors develop new functional limitations and health problems, and in cases of sepsis, approximately 40% of patients are rehospitalized within three months. Over the last few decades, better treatment approaches have been adopted. Nevertheless, the lack of knowledge underlying the complex pathophysiology of the inflammatory response organized by numerous mediators and the induction of complex networks impede curative therapy. Thus, increasing evidence indicates that resolution of an acute inflammatory response, considered an active process, is the ideal outcome that leads to tissue restoration and organ function. Many mediators have been identified as immunoresolvents, but only a few have been shown to contribute to both the initial and resolution phases of severe systemic inflammation, and these agents might finally substantially impact the therapeutic approach to severe inflammatory processes. In this review, we depict different resolution mediators/immunoresolvents contributing to resolution programmes specifically related to life-threatening severe inflammatory processes.
Enhancing osteogenesis by promoting neural network reconstruction and neuropeptide release is considered to be an attractive strategy for repairing of critical size bone defects. However, traumatic bone defects often activate the damaged sympathetic nervous system (SNS) in the defect area and release excessive catecholamine to hinder bone defect repair. Herein, a 3D printed scaffold loaded with the calcium channel blocker‐nifedipine is proposed to reduce the concentration of catecholamine present in the bone defect region and to accelerate bone healing. To this end, nifedipine‐loaded ethosome and laponite are added into a mixed solution containing sodium alginate, methacrylated gelatin, and bone mesenchymal stem cells (BMSCs) to prepare a cell‐laden scaffold using 3D bioprinting. The released nifedipine is able to close the calcium channels of nerve cells, thereby blocking sympathetic activation and ultimately inhibiting the release of catecholamine by sympathetic nerve cells, which further promotes the osteogenic differentiation and migration of BMSCs, inhibits osteoclastogenesis in vitro, and effectively improves bone regeneration in a rat critical‐size calvarial defect model. Therefore, the results suggest that sustained release of nifedipine from the scaffold can effectively block SNS activation, providing promising strategies for future treatment of bone defects.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.